Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Dermatology Drug Market Professional Survey Report 2018

  • QYR2635194
  • 111 Pages
  • June 2018
  • Healthcare
Download Sample    Get Discount   
 
This report studies the global Dermatology Drug market status and forecast, categorizes the global Dermatology Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.

Dermatology Drug is widely used for Psoriasis, Skin Infections, Acne, Dermatitis and other skin diseases. Amongst these different types of skin diseases, Psoriasis was the largest revenue generating segment in 2015, and the revenue market share is about 48.04%.

The global Dermatology Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report

AbbVie

Johnson & Johnson

Bayer

Galderma

Bristol-Myers Squibb

Novartis

Pfizer

Merz Pharma

Valeant

LEO Pharma

GlaxoSmithKline

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

India

Southeast Asia

Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

External Use

Oral

Injection

By Application, the market can be split into

Psoriasis

Skin Infections

Acne

Dermatitis

Other

The study objectives of this report are:

To analyze and study the global Dermatology Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

Focuses on the key Dermatology Drug manufacturers, to study the capacity, production, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Dermatology Drug are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Dermatology Drug Manufacturers

Dermatology Drug Distributors/Traders/Wholesalers

Dermatology Drug Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Dermatology Drug market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

Global Dermatology Drug Market Professional Survey Report 2018

1 Industry Overview of Dermatology Drug

1.1 Definition and Specifications of Dermatology Drug

1.1.1 Definition of Dermatology Drug

1.1.2 Specifications of Dermatology Drug

1.2 Classification of Dermatology Drug

1.2.1 External Use

1.2.2 Oral

1.2.3 Injection

1.3 Applications of Dermatology Drug

1.3.1 Psoriasis

1.3.2 Skin Infections

1.3.3 Acne

1.3.4 Dermatitis

1.3.5 Other

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 Europe

1.4.3 China

1.4.4 Japan

1.4.5 Southeast Asia

1.4.6 India

2 Manufacturing Cost Structure Analysis of Dermatology Drug

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Dermatology Drug

2.3 Manufacturing Process Analysis of Dermatology Drug

2.4 Industry Chain Structure of Dermatology Drug

3 Technical Data and Manufacturing Plants Analysis of Dermatology Drug

3.1 Capacity and Commercial Production Date of Global Dermatology Drug Major Manufacturers in 2017

3.2 Manufacturing Plants Distribution of Global Dermatology Drug Major Manufacturers in 2017

3.3 R&D Status and Technology Source of Global Dermatology Drug Major Manufacturers in 2017

3.4 Raw Materials Sources Analysis of Global Dermatology Drug Major Manufacturers in 2017

4 Global Dermatology Drug Overall Market Overview

4.1 2013-2018E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2013-2018E Global Dermatology Drug Capacity and Growth Rate Analysis

4.2.2 2017 Dermatology Drug Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2013-2018E Global Dermatology Drug Sales and Growth Rate Analysis

4.3.2 2017 Dermatology Drug Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2013-2018E Global Dermatology Drug Sales Price

4.4.2 2017 Dermatology Drug Sales Price Analysis (Company Segment)

5 Dermatology Drug Regional Market Analysis

5.1 North America Dermatology Drug Market Analysis

5.1.1 North America Dermatology Drug Market Overview

5.1.2 North America 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2013-2018E Dermatology Drug Sales Price Analysis

5.1.4 North America 2017 Dermatology Drug Market Share Analysis

5.2 Europe Dermatology Drug Market Analysis

5.2.1 Europe Dermatology Drug Market Overview

5.2.2 Europe 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis

5.2.3 Europe 2013-2018E Dermatology Drug Sales Price Analysis

5.2.4 Europe 2017 Dermatology Drug Market Share Analysis

5.3 China Dermatology Drug Market Analysis

5.3.1 China Dermatology Drug Market Overview

5.3.2 China 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis

5.3.3 China 2013-2018E Dermatology Drug Sales Price Analysis

5.3.4 China 2017 Dermatology Drug Market Share Analysis

5.4 Japan Dermatology Drug Market Analysis

5.4.1 Japan Dermatology Drug Market Overview

5.4.2 Japan 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Japan 2013-2018E Dermatology Drug Sales Price Analysis

5.4.4 Japan 2017 Dermatology Drug Market Share Analysis

5.5 Southeast Asia Dermatology Drug Market Analysis

5.5.1 Southeast Asia Dermatology Drug Market Overview

5.5.2 Southeast Asia 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Southeast Asia 2013-2018E Dermatology Drug Sales Price Analysis

5.5.4 Southeast Asia 2017 Dermatology Drug Market Share Analysis

5.6 India Dermatology Drug Market Analysis

5.6.1 India Dermatology Drug Market Overview

5.6.2 India 2013-2018E Dermatology Drug Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2013-2018E Dermatology Drug Sales Price Analysis

5.6.4 India 2017 Dermatology Drug Market Share Analysis

6 Global 2013-2018E Dermatology Drug Segment Market Analysis (by Type)

6.1 Global 2013-2018E Dermatology Drug Sales by Type

6.2 Different Types of Dermatology Drug Product Interview Price Analysis

6.3 Different Types of Dermatology Drug Product Driving Factors Analysis

6.3.1 External Use Growth Driving Factor Analysis

6.3.2 Oral Growth Driving Factor Analysis

6.3.3 Injection Growth Driving Factor Analysis

7 Global 2013-2018E Dermatology Drug Segment Market Analysis (by Application)

7.1 Global 2013-2018E Dermatology Drug Consumption by Application

7.2 Different Application of Dermatology Drug Product Interview Price Analysis

7.3 Different Application of Dermatology Drug Product Driving Factors Analysis

7.3.1 Psoriasis of Dermatology Drug Growth Driving Factor Analysis

7.3.2 Skin Infections of Dermatology Drug Growth Driving Factor Analysis

7.3.3 Acne of Dermatology Drug Growth Driving Factor Analysis

7.3.4 Dermatitis of Dermatology Drug Growth Driving Factor Analysis

7.3.5 Other of Dermatology Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Dermatology Drug

8.1 AbbVie

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Product A

8.1.2.2 Product B

8.1.3 AbbVie 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 AbbVie 2017 Dermatology Drug Business Region Distribution Analysis

8.2 Johnson & Johnson

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Product A

8.2.2.2 Product B

8.2.3 Johnson & Johnson 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Johnson & Johnson 2017 Dermatology Drug Business Region Distribution Analysis

8.3 Bayer

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Product A

8.3.2.2 Product B

8.3.3 Bayer 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 Bayer 2017 Dermatology Drug Business Region Distribution Analysis

8.4 Galderma

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Product A

8.4.2.2 Product B

8.4.3 Galderma 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Galderma 2017 Dermatology Drug Business Region Distribution Analysis

8.5 Bristol-Myers Squibb

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.2.1 Product A

8.5.2.2 Product B

8.5.3 Bristol-Myers Squibb 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Bristol-Myers Squibb 2017 Dermatology Drug Business Region Distribution Analysis

8.6 Novartis

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.2.1 Product A

8.6.2.2 Product B

8.6.3 Novartis 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Novartis 2017 Dermatology Drug Business Region Distribution Analysis

8.7 Pfizer

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.2.1 Product A

8.7.2.2 Product B

8.7.3 Pfizer 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Pfizer 2017 Dermatology Drug Business Region Distribution Analysis

8.8 Merz Pharma

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.2.1 Product A

8.8.2.2 Product B

8.8.3 Merz Pharma 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Merz Pharma 2017 Dermatology Drug Business Region Distribution Analysis

8.9 Valeant

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.2.1 Product A

8.9.2.2 Product B

8.9.3 Valeant 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 Valeant 2017 Dermatology Drug Business Region Distribution Analysis

8.10 LEO Pharma

8.10.1 Company Profile

8.10.2 Product Picture and Specifications

8.10.2.1 Product A

8.10.2.2 Product B

8.10.3 LEO Pharma 2017 Dermatology Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.10.4 LEO Pharma 2017 Dermatology Drug Business Region Distribution Analysis

8.11 GlaxoSmithKline

9 Development Trend of Analysis of Dermatology Drug Market

9.1 Global Dermatology Drug Market Trend Analysis

9.1.1 Global 2018-2025 Dermatology Drug Market Size (Volume and Value) Forecast

9.1.2 Global 2018-2025 Dermatology Drug Sales Price Forecast

9.2 Dermatology Drug Regional Market Trend

9.2.1 North America 2018-2025 Dermatology Drug Consumption Forecast

9.2.2 Europe 2018-2025 Dermatology Drug Consumption Forecast

9.2.3 China 2018-2025 Dermatology Drug Consumption Forecast

9.2.4 Japan 2018-2025 Dermatology Drug Consumption Forecast

9.2.5 Southeast Asia 2018-2025 Dermatology Drug Consumption Forecast

9.2.6 India 2018-2025 Dermatology Drug Consumption Forecast

9.3 Dermatology Drug Market Trend (Product Type)

9.4 Dermatology Drug Market Trend (Application)

10 Dermatology Drug Marketing Type Analysis

10.1 Dermatology Drug Regional Marketing Type Analysis

10.2 Dermatology Drug International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Dermatology Drug by Region

10.4 Dermatology Drug Supply Chain Analysis

11 Consumers Analysis of Dermatology Drug

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Dermatology Drug Market Professional Survey Report 2017

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Dermatology Drug

Table Product Specifications of Dermatology Drug

Table Classification of Dermatology Drug

Figure Global Production Market Share of Dermatology Drug by Type in 2017

Figure External Use Picture

Table Major Manufacturers of External Use

Figure Oral Picture

Table Major Manufacturers of Oral

Figure Injection Picture

Table Major Manufacturers of Injection

Table Applications of Dermatology Drug

Figure Global Consumption Volume Market Share of Dermatology Drug by Application in 2017

Figure Psoriasis Examples

Table Major Consumers in Psoriasis

Figure Skin Infections Examples

Table Major Consumers in Skin Infections

Figure Acne Examples

Table Major Consumers in Acne

Figure Dermatitis Examples

Table Major Consumers in Dermatitis

Figure Other Examples

Table Major Consumers in Other

Figure Market Share of Dermatology Drug by Regions

Figure North America Dermatology Drug Market Size (Million USD) (2013-2025)

Figure Europe Dermatology Drug Market Size (Million USD) (2013-2025)

Figure China Dermatology Drug Market Size (Million USD) (2013-2025)

Figure Japan Dermatology Drug Market Size (Million USD) (2013-2025)

Figure Southeast Asia Dermatology Drug Market Size (Million USD) (2013-2025)

Figure India Dermatology Drug Market Size (Million USD) (2013-2025)

Table Dermatology Drug Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Dermatology Drug in 2017

Figure Manufacturing Process Analysis of Dermatology Drug

Figure Industry Chain Structure of Dermatology Drug

Table Capacity and Commercial Production Date of Global Dermatology Drug Major Manufacturers in 2017

Table Manufacturing Plants Distribution of Global Dermatology Drug Major Manufacturers in 2017

Table R&D Status and Technology Source of Global Dermatology Drug Major Manufacturers in 2017

Table Raw Materials Sources Analysis of Global Dermatology Drug Major Manufacturers in 2017

Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Dermatology Drug 2013-2018E

Figure Global 2013-2018E Dermatology Drug Market Size (Volume) and Growth Rate

Figure Global 2013-2018E Dermatology Drug Market Size (Value) and Growth Rate

Table 2013-2018E Global Dermatology Drug Capacity and Growth Rate

Table 2017 Global Dermatology Drug Capacity (K Units) List (Company Segment)

Table 2013-2018E Global Dermatology Drug Sales (K Units) and Growth Rate

Table 2017 Global Dermatology Drug Sales (K Units) List (Company Segment)

Table 2013-2018E Global Dermatology Drug Sales Price (USD/Unit)

Table 2017 Global Dermatology Drug Sales Price (USD/Unit) List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E

Figure North America 2013-2018E Dermatology Drug Sales Price (USD/Unit)

Figure North America 2017 Dermatology Drug Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E

Figure Europe 2013-2018E Dermatology Drug Sales Price (USD/Unit)

Figure Europe 2017 Dermatology Drug Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E

Figure China 2013-2018E Dermatology Drug Sales Price (USD/Unit)

Figure China 2017 Dermatology Drug Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E

Figure Japan 2013-2018E Dermatology Drug Sales Price (USD/Unit)

Figure Japan 2017 Dermatology Drug Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E

Figure Southeast Asia 2013-2018E Dermatology Drug Sales Price (USD/Unit)

Figure Southeast Asia 2017 Dermatology Drug Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption (K Units) of Dermatology Drug 2013-2018E

Figure India 2013-2018E Dermatology Drug Sales Price (USD/Unit)

Figure India 2017 Dermatology Drug Sales Market Share

Table Global 2013-2018E Dermatology Drug Sales (K Units) by Type

Table Different Types Dermatology Drug Product Interview Price

Table Global 2013-2018E Dermatology Drug Sales (K Units) by Application

Table Different Application Dermatology Drug Product Interview Price

Table AbbVie Information List

Table Product Overview

Table 2017 AbbVie Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 AbbVie Dermatology Drug Business Region Distribution

Table Johnson & Johnson Information List

Table Product Overview

Table 2017 Johnson & Johnson Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Johnson & Johnson Dermatology Drug Business Region Distribution

Table Bayer Information List

Table Product Overview

Table 2017 Bayer Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Bayer Dermatology Drug Business Region Distribution

Table Galderma Information List

Table Product Overview

Table 2017 Galderma Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Galderma Dermatology Drug Business Region Distribution

Table Bristol-Myers Squibb Information List

Table Product Overview

Table 2017 Bristol-Myers Squibb Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Bristol-Myers Squibb Dermatology Drug Business Region Distribution

Table Novartis Information List

Table Product Overview

Table 2017 Novartis Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Novartis Dermatology Drug Business Region Distribution

Table Pfizer Information List

Table Product Overview

Table 2017 Pfizer Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Pfizer Dermatology Drug Business Region Distribution

Table Merz Pharma Information List

Table Product Overview

Table 2017 Merz Pharma Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Merz Pharma Dermatology Drug Business Region Distribution

Table Valeant Information List

Table Product Overview

Table 2017 Valeant Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Valeant Dermatology Drug Business Region Distribution

Table LEO Pharma Information List

Table Product Overview

Table 2017 LEO Pharma Dermatology Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 LEO Pharma Dermatology Drug Business Region Distribution

Table GlaxoSmithKline Information List

Figure Global 2018-2025 Dermatology Drug Market Size (K Units) and Growth Rate Forecast

Figure Global 2018-2025 Dermatology Drug Market Size (Million USD) and Growth Rate Forecast

Figure Global 2018-2025 Dermatology Drug Sales Price (USD/Unit) Forecast

Figure North America 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast

Figure China 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast

Figure Europe 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast

Figure Southeast Asia 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast

Figure Japan 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast

Figure India 2018-2025 Dermatology Drug Consumption Volume (K Units) and Growth Rate Forecast

Table Global Sales Volume (K Units) of Dermatology Drug by Type 2018-2025

Table Global Consumption Volume (K Units) of Dermatology Drug by Application 2018-2025

Table Traders or Distributors with Contact Information of Dermatology Drug by Region

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370